Pharmadeal Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.99 M
- Company Age 47 Year, 29 Days
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth 2998.58%
- Ebitda -494.29%
- Net Worth 41.92%
- Total Assets -0.83%
About Pharmadeal
Pharmadeal Private Limited (PPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 January 1978 and has a history of 47 years. Its registered office is in Jabalpur, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.99 M, as per Ministry of Corporate Affairs (MCA) records.
Nitin Tiwari and Rahul Kothari serve as directors at the Company.
Company Details
-
Location
Jabalpur, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U02423MP1978PTC001431
-
Company No.
001431
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Jan 1978
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Pharmadeal?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Tiwari
|
Director | 04-Jun-2020 | Current |
|
Rahul Kothari
|
Director | 11-Apr-2019 | Current |
Financial Performance of Pharmadeal.
Pharmadeal Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 2998.58% increase in profit. The company's net worth Soared by an impressive increase of 41.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmadeal?
In 2019, Pharmadeal had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Rayns Mining Private LimitedNitin Tiwari is a mutual person
-
Shoonya Mobility Private Limited
Nitin Tiwari is a mutual person
-
J M Projects Private Limited
Nitin Tiwari is a mutual person
-
J M Buildtech (India) Private Limited
Nitin Tiwari is a mutual person
-
Ojas Buildcon Private Limited
Nitin Tiwari is a mutual person
-
Rayns Media & Entertainment Private Limited
Nitin Tiwari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmadeal?
Unlock and access historical data on people associated with Pharmadeal, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmadeal, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmadeal's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
